Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Benchmarks provide a reference point to gauge portfolio performance and risk. This intro explains how comparing returns against a relevant benchmark clarifies decisions and helps align goals.
22,975 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
A margin increase on COMEX silver futures unleashed a swift selloff, sending prices skidding and testing key support....
South Korea faces a major shift as lawmakers push to abolish the crypto capital gains tax amid a dramatic capital fli...
SolarEdge leads a solar-stock surge, jumping about 14% as Canadian Solar adds strength. Investors cite AI infrastruct...
Today’s market shows a blend of volatility and opportunity. Planet Labs led a surge on strong earnings, while broader...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
Geopolitical tensions between the U.S. and Iran are dominating crypto moves, with Bitcoin and XRP trading in tight ra...
Here Tuesday’s Wall Street roundup highlights fresh analyst calls across airlines, energy and software as markets nav...
Barclays and Truist each updated price targets for Carnival ahead of the March 27, 2026 Q1 release, signaling a split...
XRP’s Bollinger Bands have tightened once more, reviving chatter of a possible breakout. Here’s what traders are watc...
A sweeping defense modernization plan totaling $185 billion could lift software-focused players like Palantir as miss...
Cardano just caught major regulatory clarity, a development that could reduce some risk for investors. This guide bre...